Related Experiment Video
Updated: May 7, 2025
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.5K
[Curative Treatment for COPD Based on Differentiation Induction by Synthetic Retinoid Am80 and Development of
1Department of Pharmaceutics and Drug Delivery, Faculty of Pharmaceutical Sciences, Tokyo University of Science.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|January 5, 2025
Summary
New treatments are needed for chronic obstructive pulmonary disease (COPD) to repair alveolar destruction. Researchers discovered the synthetic retinoid Am80 and developed a drug delivery system for alveolar regeneration therapy.
Area of Science:
- Regenerative Medicine
- Pulmonary Medicine
- Drug Delivery Systems
Background:
- Chronic obstructive pulmonary disease (COPD) involves chronic bronchitis and emphysema, with current treatments offering only symptomatic relief.
- Alveolar destruction in COPD necessitates novel therapeutic strategies focused on tissue regeneration.
- Alveolar epithelial progenitor cells hold potential for regenerating damaged lung tissue.
Purpose of the Study:
- To explore alveolar regeneration therapy for COPD by focusing on the differentiation of alveolar epithelial progenitor cells.
- To develop a drug delivery system (DDS) for efficient delivery of regenerative drugs to alveolar stem cells.
- To identify and evaluate candidate drugs for inducing alveolar regeneration.
Main Methods:
- Discovery of novel alveolar regeneration drugs using human alveolar epithelial progenitor cells.
- Development of a drug delivery system (DDS) leveraging biological mechanisms to enhance therapeutic effects.
- Formulation design of a dry powder inhalation system for targeted drug delivery.
Main Results:
- Identification of the synthetic retinoid Am80 as a promising candidate drug for alveolar regeneration.
- Successful construction of a DDS designed to improve the efficacy of alveolar regeneration.
- Development of a dry powder inhalation formulation for effective drug delivery.
Conclusions:
- Alveolar regeneration therapy holds promise for treating COPD by targeting alveolar stem cells.
- The synthetic retinoid Am80, delivered via a specialized DDS and dry powder inhalation, represents a novel therapeutic approach for COPD.
- Further development of this DDS and drug combination could lead to effective treatments for alveolar destruction in COPD patients.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
117
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
117
01:23Inhaled Medications
195
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
195
01:17Drugs Used in Lower Respiratory Disorders: Overview
241
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
241
01:20COPD: Pathogenesis and Clinical Features
168
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
168
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
131
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
131
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K